| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |